Increasing access to CAR-T therapy: a case study of an academic hospital's alternative innovation model

Orphanet J Rare Dis. 2026 Apr 10. doi: 10.1186/s13023-026-04320-7. Online ahead of print.
No abstract available

Keywords: Academic development; Access to medicines; Acute lymphoblastic leukemia; Advance therapy medicinal products; Advanced therapies; Alternative innovation models; CAR-T therapies; Hospital exemption; Orphan drugs; Pharmaceutical innovation.